Presbia PLC | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
9,462.00
15,664.00
18,161.00
15,757.00
16,998.00
Depreciation, Depletion & Amortization
96.00
138.00
173.00
253.00
477.00
Other Funds
5,376.00
9,247.00
1,141.00
1.00
510.00
Funds from Operations
5,644.00
9,312.00
15,317.00
13,014.00
15,179.00
Changes in Working Capital
823.00
202.00
336.00
389.00
1,208.00
Net Operating Cash Flow
4,821.00
9,514.00
15,653.00
13,403.00
13,971.00
Capital Expenditures
147.00
179.00
196.00
805.00
198.00
Net Investing Cash Flow
147.00
179.00
196.00
805.00
198.00
Issuance/Reduction of Debt, Net
-
-
-
167.00
-
Net Financing Cash Flow
5,376.00
9,247.00
37,460.00
166.00
10,024.00
Net Change in Cash
408.00
446.00
21,611.00
14,416.00
4,097.00
Free Cash Flow
4,968.00
9,647.00
15,849.00
13,543.00
14,044.00
Change in Capital Stock
-
-
36,319.00
-
10,534.00
Exchange Rate Effect
-
-
-
42.00
48.00

About Presbia

View Profile
Address
Sandyford Office Centre
Dublin Dublin 18
Ireland
Employees -
Website http://www.presbia.com
Updated 09/14/2018
Presbia Plc is a medical device company, which engages in the development and marketing of presbyopia-correcting solutions under the trademark of Presbia Flexivue Microlens. It operates through the Restoration of Clear Vision Caused by Presbyopia segment. The company was founded on February 2, 2014 and is headquartered in Dublin, Ireland.